The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.
about
A review of perioperative anesthesia and analgesia for infants: updates and trends to watch.Prediction of Human Glomerular Filtration Rate from Preterm Neonates to Adults: Evaluation of Predictive Performance of Several Empirical ModelsMethods for pharmacokinetic analysis in young children.Prediction of glucuronidated drug clearance in pediatrics (≤5 years): An allometric approach.Tailored tools to improve pharmacotherapy in infants.Prediction of drug clearance in children: an evaluation of the predictive performance of several models.Prediction of drug clearance in children: a review of different methodologies.Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Pharmacological sedation management in the paediatric intensive care unit.Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.Prediction of Clearance in Neonates and Infants (≤ 3 Months of Age) for Drugs That Are Glucuronidated: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?A bodyweight-dependent allometric exponent model for scaling clearance of clotting factor VIII and IX from infants to adults.
P2860
Q34552020-C2A706A2-D322-45C2-B2C5-57C5540A59BDQ36653892-EF986487-86D2-4B9D-AF19-5D5FAA7AA7B9Q38187157-E27DA926-6C8B-4D7F-B37E-A0BF75444931Q38187348-C503C2E0-E729-4409-8D66-605EFE7CE0FCQ38222870-82754F71-2974-4434-A60F-7E547E03B439Q38256006-AB7E3429-33D3-44D7-B71D-B318A0172A7FQ38367747-0394ADA6-6465-4CBF-88F8-0027B32AA722Q38599526-960742CA-6A39-4A5B-B645-394FFEBEA265Q38696468-EF52843D-548B-4CE4-AFFC-705EF652F0BDQ38829350-A2AE708C-6175-4491-9550-24799A6E1B01Q38838930-4C48FCDB-3575-4384-B494-B10FB9D9B5CDQ38937378-D0EAC805-9863-45A5-82D3-8DEEACB3C1CAQ38972571-8837A3BB-C8B9-4B21-8B21-9DD19C79B621Q42320775-319CDDFF-6941-40B2-9C4B-33F3F0846EF8Q45862027-4B2B441A-93DF-4EA8-9E3C-0904125A2723
P2860
The allometric exponent for scaling clearance varies with age: a study on seven propofol datasets ranging from preterm neonates to adults.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The allometric exponent for sc ...... om preterm neonates to adults.
@en
The allometric exponent for sc ...... om preterm neonates to adults.
@nl
type
label
The allometric exponent for sc ...... om preterm neonates to adults.
@en
The allometric exponent for sc ...... om preterm neonates to adults.
@nl
prefLabel
The allometric exponent for sc ...... om preterm neonates to adults.
@en
The allometric exponent for sc ...... om preterm neonates to adults.
@nl
P2093
P2860
P356
P1476
The allometric exponent for sc ...... om preterm neonates to adults.
@en
P2093
Catherijne A J Knibbe
Chenguang Wang
Karel Allegaert
Mariska Y M Peeters
Meindert Danhof
P2860
P304
P356
10.1111/BCP.12180
P407
P50
P577
2014-01-01T00:00:00Z